bioAffinity Technologies (BIAF) Depreciation and Depletion (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Depreciation and Depletion of $24408.0 for Q1 2026, down 44.23% year-over-year from $43763.0 in Q1 2025, and down 34.96% quarter-over-quarter from $37529.0 in Q4 2025.
bioAffinity Technologies (BIAF) Depreciation and Depletion (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Depreciation and Depletion for 5 consecutive years, with $24408.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation and Depletion fell 44.23% year-over-year to $24408.0; the TTM figure through Mar 2026 stood at $151004.0 (down 9.73% YoY), while the FY2025 annual figure was $170359.0, up 4.94% from the prior year.
- Depreciation and Depletion fell to $24408.0 in Q1 2026 per BIAF's latest filing, from $37529.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $166284.0 in Q4 2023 and bottomed at $800.0 in Q3 2022.
- Historically, Depreciation and Depletion has averaged $36543.8 across 5 years, with a median of $38811.0 in 2024.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion soared 5536.88% — and 2024, when it slumped 74.26%.
- bioAffinity Technologies' Depreciation and Depletion stood at $7282.0 in 2022, then jumped by 2183.49% to $166284.0 in 2023, then plunged by 74.26% to $42806.0 in 2024, then fell by 12.33% to $37529.0 in 2025, then sank by 34.96% to $24408.0 in 2026.
- Business Quant data shows BIAF's Depreciation and Depletion at $24408.0 in Q1 2026, $37529.0 in Q4 2025, and $44599.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 331.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 196.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 7.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.60 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 51.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 13.30 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 108.00 Mn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 24,408.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,408.00 |
| Mar 31, 2026 | 24,408.00 |
| Dec 31, 2025 | 37,529.00 |
| Dec 31, 2025 | 37,529.00 |
| Sep 30, 2025 | 44,599.00 |
| Sep 30, 2025 | 44,599.00 |
| Jun 30, 2025 | 44,468.00 |
| Jun 30, 2025 | 44,468.00 |
| Mar 31, 2025 | 43,763.00 |
| Mar 31, 2025 | 43,763.00 |
| Dec 31, 2024 | 42,806.00 |
| Dec 31, 2024 | 42,806.00 |
| Sep 30, 2024 | 40,472.00 |
| Sep 30, 2024 | 40,472.00 |
| Jun 30, 2024 | 40,243.00 |
| Jun 30, 2024 | 40,243.00 |
| Mar 31, 2024 | 38,811.00 |
| Mar 31, 2024 | 38,811.00 |
| Dec 31, 2023 | 166,284.00 |
| Dec 31, 2023 | 166,284.00 |